Cancer Researcher at Mayo Says Illumina Platform Maxing Out, Looks to BGI/Complete

Today we bring you a story which you probably wouldn’t have heard at last week’s AGBT conference at Marcos Island. While PacBio and 10X Genomics were getting most of the buzz at the annual show on all things sequencing, it could be the new BGI/Complete Genomics platform that steals the show later this year, says David Smith, a cancer researcher at the Mayo Clinic.In his research, David uses sequencing to analyze the connection between the human papillomavirus (HPV) with oropharyngeall cancer. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe